English | Español
Tabitha Fleming | Jun 2, 2017

European Commission approves dinutuximab beta for treating high-risk neuroblastoma
Tabitha Fleming | Jun 2, 2017

Merck's Keytruda approved for treating Hodgkin's lymphoma in Europe
Tabitha Fleming | May 26, 2017

National Institute on Alcohol Abuse and Alcoholism releases 5-year action plan
Tabitha Fleming | May 26, 2017

American Academy of Family Physicians supports guidelines for osteoporosis treatment
Tabitha Fleming | May 25, 2017

Nautilus Medical working to increase patient access to radiology reports
Tabitha Fleming | May 14, 2017

Lupus Foundation of America promotes awareness of disease
Tabitha Fleming | Mar 10, 2017

Genetic engineering could make jeans cheaper to produce
Tabitha Fleming | Mar 1, 2017

Utah, Lousiana issue standing order for opioid overdose drug

Trending
+ Pharmaceuticals
Patient Daily | Jun 30, 2025

PhRMA public affairs senior director on 340B program: 'PBMs took $140 billion in rebates and fees, driving up American medicine costs'
+ Pharmaceuticals
Patient Daily | Jun 25, 2025

Neurosurgeon at the University of California: ‘340B is being exploited for profit, not patient care’
+ Pharmaceuticals
Patient Daily | Jul 1, 2025

PhRMA chief public affairs officer on 340B drug pricing: ‘Lowering drug prices for U.S. patients starts by reining in middlemen’